JAK1i |
Filgotinib |
II |
Noninfectious Uveitis |
NCT03207815 |
|
|
III |
Ankylosing Spondylitis |
NCT04483700 |
|
|
III |
Psoriatic Arthritis |
NCT04115839 |
|
|
II |
Lupus Membranous Nephropathy |
NCT03285711 |
|
|
II |
Cutaneous Lupus Erythematosus |
NCT03134222 |
|
|
I |
Renal Impairment |
NCT02084199 |
|
|
II |
Sjogren’s Syndrome |
NCT03100942 |
|
|
II |
Inflammatory Bowel Disease |
NCT03201445 |
|
PF04965842 |
I, III |
Dermatitis, Atopic |
NCT03634345 |
|
|
II |
Plaque Psoriasis |
NCT02201524 |
|
Oclacitinib |
Approved |
Atopic dermatitis |
|
JAK2i |
GSK2586184 |
I |
Colitis, Ulcerative |
NCT02000453 |
|
|
I |
Systemic Lupus Erythematosus |
NCT01953835 |
|
|
I |
Psoriasis |
NCT01782664 |
|
|
I, II |
Systemic Lupus Erythematosus |
NCT01687309;
NCT01777256 |
|
Pacritinib |
I |
Myelofibrosis |
NCT02765724 |
|
|
II |
Prostates Cancer |
NCT04635059 |
|
|
II |
Acute Myeloid Leukemia (AML) |
NCT02532010 |
|
|
I |
Lymphoma, T-Cell, Cutaneous |
NCT03601819 |
|
|
|
Lymphoma, T-Cell, Peripheral |
|
|
|
|
Chronic Lymphocytic Leukemia |
|
|
|
II |
Colorectal Cancer |
NCT02277093 |
|
|
II |
Leukemia |
NCT02469415 |
|
|
I, II |
GVHD |
NCT02891603 |
|
|
I |
Non-Small Cell Lung Cancer |
NCT02342353 |
Selectivity |
Preparation |
Status |
Approval |
NCT
Number |
JAK2i |
Pacritinib |
I |
Non-Small
Cell Lung Cancer |
NCT02342353 |
|
|
I, II |
Breast Cancer |
NCT04520269 |
|
|
III |
COVID19 |
NCT04404361 |
JAK3i |
PF-06651600 |
II, III |
Alopecia Areata |
NCT03732807;
NCT02974868; NCT04006457; NCT04517864 |
|
|
II |
Rheumatoid Arthritis |
NCT02969044; NCT04413617 |
|
|
II |
Ulcerative Colitis |
NCT02958865 |
|
|
II |
Crohn’s Disease |
NCT03395184 |
TYK2i |
BMS986165 |
II, III |
Psoriasis; Plaque Psoriasis |
NCT05065762;
NCT02931838; NCT03611751; NCT04167462; NCT03924427; NCT04036435;
NCT04772079 |
|
|
III |
Psoriatic Arthritis |
NCT04908189; NCT04908202 |
|
|
II
|
Ulcerative Colitis; Colitis, Ulcerative; Granulomatous;
Colitis Crohn’s Disease;
Crohn’s Enteritis;
Granulomatous Enteritis
|
NCT03934216; NCT04613518; NCT03599622; NCT04877990
|
|
|
II
|
Systemic Lupus Erythematosus;
Lupus Erythematosus,
Discoid Lupus Erythematosus; Subacute Cutaneous
|
NCT03252587; NCT04857034
|
|
PF-06826647 |
II |
Psoriasis |
NCT03895372 |
|
|
II |
Ulcerative Colitis |
NCT04209556 |
|
|
II |
Acne Inversa |
NCT04092452 |
|
PF-06835375 |
II |
Primary Immune Thrombocytopenia |
NCT05070845 |